Copenhagen, Denmark) using 0.2 N HCl. The reaction mixture was left overnight at room temperature, dialyzed against six changes of phosphate-buffered saline (PBS) in the cold, sterile filtered through a millipore filter (0.45 #m), and stored at 4°C until required. The degree of cationization was estimated from isoelectric focusing in a slab gel system (Desaga, Heidelberg, F. R. G.). The reaction conditions given produced eationized human IgG with a pI exceeding 9.5, and this was used throughout the study. To check for the presence of aggregated material, the cationized human IgG was run on 7.5% polyacrylamide gel using a basic gel system (18) . Staining with amidoschwarz indicated that the cationized preparation consisted of 90% monomer, ~5% dimer, and 1-2% larger polymers. Analysis by gel column filtration was less satisfactory, because the material apparently interacts with the gel matrix, as reported by other workers (15) .
Antisera. Antisera to human IgG were raised in rabbits by repeated injections of antigen in completed Freund's adjuvant. All anti-human IgG antibody used was from a single pool, with an antigen-binding capacity of 1280 #g/ml, measured by the P-80 method (19) . The IgG fraction of this pool was isolated by repeated ammonium sulphate precipitation.
Radiolabeling. Cationized human IgG and the IgG fraction of rabbit anti-human IgG were labeled with l~I and laXI, respectively, by the chloramine-T method (20) . Labeled preparations in which >95% of the isotope was protein bound were used. The specific activity was 1 × 10 7 to 3 × 107 cpm/mg of l~I-labeled cationized human IgG and 3 × 106 to 4 × 105 cpm/mg of ~31I-labeled anti-human IgG. Before use, the preparation was diluted with the appropriate amount of unlabeled material that had been treated with chloramine-T. Total amounts of t25I-labeled cationized human IgG injected were equivalent to 6 × 104 to 8 × 104 cpm/animal, and in the case of Ia~I-labeled anti-human IgG an equivalent of 1 × 105 to 1.5 × l0 b cpm/animal was injected. Radioactivity was determined in a well-type gamma counter Berthold, 7547 Wildbad, F. R. G. (LB MAG 3/2; Berthold, Wildbad, Federal Republic of Germany).
Unilateral Renal Perfusion. A number 23 needle (Record) was used to canulate the left renal artery, and the left kidney was perfused with 0.5 ml PBS, followed by the test material in a volume of 0.2 ml, both at a rate of 0.5 ml/min, after which the tubing was flushed with an additional 0.1 ml PBS. The period of ischemia ranged from 4 to 7 min. 24 -h urinary specimens were collected in metabolic cages, centrifuged at 1000 g for 10 min, and the protein content was measured with the biuret method (21) using human serum albumin as standard.
Estimation of Proteinuria.
Histological Examination. For light microscopy, renal tissue was fixed in buffered formalin, embedded in paraffin, and 4-#m sections were stained with hematoxilin-eosin, periodic acidSchiff, or periodic acid silver methamine. For immunofluoreseence, material was snap-frozen in n-hexane cooled to -70°C. Frozen sections were stained with monospecific fluorescein isothiocyanate (FITC)-conjugated anti-human IgG (Behringwerke), anti-rabbit IgG, anti-rat IgG, and anti-rat C3 (Nordic Immunochemicals, Tilberg, Holland). Tissue fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) was processed for electron microscopy as described by Zollinger and Mihatsch (22) .
Experimental Design. Five groups of experiments were performed according to the following schedules; three to five rats were used per experiment at each time point studied.
l. DISTRIBUTION OF CATIONIZED HUMAN IgG At~rER INTRAVENOUS INJECTION. Rats were given I mg of 125I-labeled cationized human IgG in I mt PBS and killed 1 h later, and the activity in the left and right kidney and in samples of blood, spleen, liver, lung, and heart was determined. 3. NEPHRITOGENIC POTENTIAL OF CATIONIZED HUMAN IgG PLANTED IN THE GLOMERULUS AFTER INTRAVENOUS ADMINISTRATION OF ANTI-HUMAN IgG ANTISERUM. 5-100 /tg of cationized human IgG was perfused directly into the left kidney via the renal artery. 1 h later, the rats were injected with 0.5 ml rabbit anti-human IgG antiserum intravenously. As controls, the following two experiments were done: (a) perfusion of 100 ~g of normal human IgG, followed by 0.5 ml of anti-human IgG intravenously 1 h later; and (b) perfusion of 50/~g ofcationized human IgG, followed by 0.5 ml of normal rabbit serum 1 h later. Urinary protein excretion was examined daily for a period of up to 4 wk. Renal tissue was taken for immunofluorescent study at intervals between 1 h and 3 too, and for light and electron microscopy between 1 d and 3 too. 4 . DEGREE OF BINDING OF ANTI-HUMAN IgG ANTIBODY TO A PREVIOUSLY PLANTED, NEPHRITOGENIC DOSE OF CATIONIZED HUMAN Ig~. A group of rats were perfused with 20 Rg of cationized human IgG (for selection of dose, see Results) into the left renal artery, and 2 h later 1.0-10 mg of 131I-labeled anti-human IgG antibody globulin was given intravenously. 72 h later, rats were killed, and the quantity of anti-human IgG in each kidney was determined. For controls, rats were perfused via the left renal artery with 20 #g of native human IgG, and 1 h later were given 2.5 mg of 131I-labeled anti-human IgG antibody globulin intravenously; second, rats were injected with 2.5 mg of 181I-labeled normal rabbit IgG 1 h after perfusion of the left kidney with 20 pg of cationized human IgG. The value for renal binding of 131I-anti-human IgG in the left kidney was corrected for blood contamination by deducting the counts found in the right kidney. Binding of anti-human IgG to the cationized human IgG localized in the kidneys was also checked for by immunofluorescence. For these experiments, rats were perfused with up to 100/~g of cationized human IgG into the left renal artery, followed by intravenous injection of 0.5 ml of anti-human IgG 1 h later, and were killed 1 h after injection. As a control, normal rabbit serum was substituted for the anti-human IgG antiserum. 5 
Distribution of Cationized Human IgG after Intravenous Administration.
The distribution of cationized human IgG 1 h after intravenous injection is shown in Fig. 1 , which is ~20 pg (2%) of the total dose injected (1 mg) localized per kidney. The major site of antigen localization was the liver (20%).
Distribution of Cationized Human IgG after Perfusion into the Left Kidney.
Results obtained 1 h after perfusion (Table I) showed that, with doses of between 5 and 50 /~g cationized human IgG, the amount bound to the left kidney increased linearly and was "-50% of the total injected. In the right kidney a maximum of 0.5% of the injected dose was present (blood contamination presumably contributed to this value [ Fig.  2] ). In the cases of doses of 100 and 200 #g cationized human IgG, the fraction of antigen localizing in the perfused kidney fell to 33 and 23%, respectively. In parallel, the amount of antigen present in the right kidney increased, reaching 2.2% of the total injected, equivalent to a maximum of 12.5% of the quantity found in the left kidney.
Positive fluorescence along the GBM was confined to the left kidney with a dose of up to 100 ~g of cationized human IgG. The interstitium was negative. A dosage of 200/~g resulted in positive immunofluorescence in the right kidney as well. Positive interstitial staining was observed in the left kidney. Fig. 2 shows the whole body 
Nephritogenic Potential of Cationized Human IgG Planted in the GBM after Passive Administration of Anti-Human IgG Antiserum.
These experiments were performed with a standard volume of antiserum (0.5 ml), which had an antigen-binding capacity of 640 pg. The degree of proteinuria induced depended on the dose of cationized human IgG previously administered. 10 ~g of antigen or less produced a mild proteinuria, and rats given 20/lg or more of cationized human IgG developed a severe glomerulonephritis, with a proteinuria of at least 100 mg/24 h. The time of onset as well as the persistence of proteinuria depended on the dose of antigen perfused (Table II) . No abnormal proteinuria was observed in control experiments.
Immunofluorescence revealed deposition of human IgG and rabbit IgG along the glomerular capillary wall (Fig. 3 a, b) . These deposits appeared confluent on the first 2 d (Fig. 4 a) and became more granular during the course of the disease (Fig. 4 b) . Moderate staining for rat C3 was seen at 1 h (the earliest time tested) and remained four rats were each perfused with 20/Lg I-cattomzed human IgG. 1 h later rats were killed, and activity in the various samples was measured. fairly constant within the first 2 wk, declining thereafter. The pattern was similar to that of the human IgG. Complement deposition clearly preceded development of proteinuria. Rat IgG was detectable in the capillary walls from approximately day 7 onwards. By this time the proteinuria was declining, and a second phase was not seen. Electronmicroscopy revealed a prominent accumulation of electron dense deposits, mainly in the subepithelial space and beneath slit pores ( visible on day 1, the earliest time point investigated. Glomerular hypercellularity was not pronounced.
Binding of Anti-Human IgG Antibody to Planted Cationized Human IgG. 20 #g of
cationized h u m a n IgG was chosen for these experiments (see Table II) , and a m i n i m u m of 2.5 mg of 131I-labeled anti-human IgG had to be injected intravenously to regularly induce proteinuria. In absolute values, 35.9/~g of antibody IgG was found in the left kidney on day 3, whereas only 4.0 ~g was found in the right kidney, giving a corrected uptake of 31.9/~g in the left kidney (see Materials and Methods). The quantity of 131I-labeled anti-human IgG antibody bound to the left kidney increased with the quantity of anti-human IgG injected (Table III) kidney corresponded to contamination with -0 . 1 ml blood (Table III) , an acceptable estimate confirming the suitability of the formula used.
Disappearame Kinetics of Intravenously Administered 125I-labeled Cationized Human IgG from the Kidney.
T h e rate of removal of intravenously injected 12~I-labeled cationized h u m a n lgG from the kidneys is shown in T a b l e IV. 21.1 and 20.6 #g of cationized h u m a n IgG were b o u n d in the left and right kidneys, respectively, 1 h after injection. There followed a relatively rapid decrease up to 6 h, with a subsequently slower rate of disappearance.
Disappearance Kinetics of Cationized Human IgG Perfused Directly into Left Kidney and
Effect of Subsequent Administration of Antibody. Fig. 6 shows the disappearance kinetics ofcationized h u m a n IgG from the perfused kidney with and without passive injection Fla. 5. The electron microscopic appearance of a glomerulus from a rat 3 d after perfusion of 20 gg cationized human IgG followed by intravenous injection of anti-human IgG. Massive subepithelial electron dense deposits are present (× 39,000). of antibody. There was a remarkable difference between the removal rates of antigen in both groups. After perfusion with 20 #g of t25I-labeled cationized human IgG, antigen disappeared from the kidney just as rapidly as in the case of 1.0 mg of antigen given intravenously. In contrast, a significant proportion of the cationized human IgG was removed more slowly from the perfused kidney when 2.5 mg of anti-human IgG antibody globulin had been given subsequently. 1.3 #g of cationized human IgG was still fixed to the perfused kidney on day 21. From the results shown in Fig. 6 , it could be calculated that -12 d were needed until one-half of the 125I-labeled cationized human IgG, fixed on day 1, had been removed from the perfused kidney.
Disappearance Kinetics of laal-labeled Anti-Human lgG Antibody from the Kidney after In Situ lmmune Complex Formation at Nephritogenic Levels.
After in situ immune complex formation at nephritogenic levels (perfusion of 20 #g of cationized human IgG, intravenous injection of 2.5 mg xaaI-labeled anti-human IgG), the amount of antihuman IgG antibody in the perfused kidney remained almost unchanged during the first week. A more marked loss of antibody from the kidney was seen between days 7 and 14 (Fig. 7) . 
Discussion
The idea that the deposition of circulating immune complex in the glomerular filtration harrier could be an initiating event in glomerulonephritis was unchallenged for many years. This consensus was derived from detailed analysis of acute and chronic serum sickness models (23, 24) . In particular, subepithelial depbsits were thought to be formed by this route in addition to the frequently occuring subendothelial and mesangial immune deposits. The earlier suggestion that serum sickness nephritis was caused by in situ formation of immune complex (25) was more recently revived to explain observations relating to subepithelial deposit formation in Heymann (1, 2) and Lupus nephritis (26) . The probability of an in situ immune complex is more likely with antigens that can interact with structures of the GBM; cationic proteins fulfill this requirement (4) (5) (6) 15 ). An essential property of the GBM is the presence of discrete fixed anionic sites in the lamina tara externa and interna that convey an overall negative charge to the membrane (9, 10, 14) . Previous studies (4) demonstrated that intravenously injected cationic moieties bound to the GBM if their molecular weight did not exceed a critical value lying between 500,000 and 900,000 and their pI was >8.5-9.5. Experiments employing the method of unilateral renal perfusion showed that cationized human IgG and cationized horse spleen ferritin can act as planted antigens with which circulating antibody can react to form an in situ immune complex and induce massive proteinuria (5, 6) . In this investigation, quantitative analysis of such a model was undertaken to measure the minimum quantities of antigen and antibody necessary for induction of kidney damage as well as to determine the fate of the complex. Cationized human IgG was selected because ferritin cannot be stably radioiodinated in our hands.
Cationized proteins localize throughout the body when injected intravenously, and under the conditions used here, -4% of the cationized human IgG was found in the kidneys. This is explained by the high affinity of cationic substances for negative charges found throughout the vascular bed and on blood components, such as erythrocytes (17) or platelets (10) . Unilateral renal perfusion via the left renal artery was used to preferentially localize the test material into the kidney. Provided that <100/~g of antigen was perfused, no antigen could be detected in the unperfused kidney by immunofluorescence. Up to 56% of the injected dose was found in the left kidney after 1 h, and at this time <1% still circulated. This effectively excludes the possibility that a significant deposition of circulating immune complexes could occur after passive administration of antibody. The absolute quantity of cationized human IgG deposited in the kidney increased with dose, although the percentage localizing fell from 50/~g downwards. We believe that saturation of the anionic sites in the GBM occurs and that additional antigen is localized elsewhere in the kidney; the finding of positive interstitial fluorescence only with higher doses supports this view. Administration of as little as 20/xg of high cationized human IgG (pI > 9.5) directly into the left renal artery and systemic injection of 2.5 mg of the IgG fraction of antihuman IgG 1 h later regularly induced a massive proteinuria in rats. This demonstrates clearly that only minimal amounts of antigen and antibody are necessary to cause overt kidney disease. At the time of antibody injection, 11.1 + 0.8 /~g of cationized human IgG was initially planted in the perfused left kidney, and there was only 0.07/xg in the unperfused right kidney (0.6% of the dose in the left kidney). At the onset of proteinuria, ~4 ktg antigen and ~30/~g anti-human IgG antibody were present in the perfused kidney. It is interesting to compare the dose of antigen and antibody needed to induce renal damage in our model with those measured in other models of immunologic experimental glomerulonephritis. Relevant work concerning renal injury induced by passively given antibody against heterologous nephrotoxic gammaglobulin, which played the role of fixed antigen, was performed by Unanue and Dixon (27) in rats. They showed that 12-40 /xg of kidney-fixing antibody (nephrotoxic antibody), which itself produced no proteinuria, had to be available as target antigen to induce proteinuria. In the model of one-shot serum sickness, a mean of 10/~g of bovine serum albumin (BSA) was deposited per kidney after elimination of BSA from the circulation (28) . These values are of the same order as the quantity of cationic antigen required in our system.
When administered alone the majority of the cationized human IgG was removed from the kidneys within hours. Initially, immunofluorescence showed the antigen to be distributed in a virtually linear pattern along the GBM, reflecting the high density of antigen deposits. With time, the pattern became granular in nature and the intensity decreased, and by 24 h the glomeruli were mostly negative.
After binding of antibody, the removal of antigen from the kidney was retarded, and 12 d was needed to remove one-half of the cationized human IgG. With the exception of the first 1 or 2 d, the immunofluorescent staining pattern for antigen and antibody was granular in nature. Deposition of rat C3 clearly preceded induction of proteinuria. We have not investigated whether complement is essential in causing tissue damage in this system. Rat IgG was first observed after 7 d, when the proteinuria was in decline and no second phase was seen, as usually occurs in nephrotoxic nephritis. This indicates that subsequent fixation of rat antibody to the immune deposits has little influence on the course of the disease. Electron microscopy revealed massive subepithelial dense deposit formation showing great similarity to findings in some human glomerulonephritides. In our system (cationic antigen) and in one-shot serum sickness (28) (anionic antigen), the antigens were removed from the kidneys with a similar half-life of 10-14 d, indicating that the charge of the antigen had little influence on elimination from the complex. Cationized human IgG was removed faster from the kidney than the antibody, the binding of which remained almost unchanged during the first week. Perhaps the remaining circulating antibody continued to bind to deposited antigen or to the antigen-antibody complex in the kidney, or antigen was indeed removed faster than antibody from the immune complex. In addition, some antigen may be located in a part of the kidney not accessible to antibody and may therefore be eliminated independently.
A difference in the disappearance of antigen and antibody has been described by Fish et al. (29) , who examined the course of one-shot serum sickness nephritis using immunofluorescence. However, it is not certain that a real difference exists here, because it was proposed (28) that the antigen may be masked but still be present. The half-life of kidney-fixed gamma globulin in nephrotoxic nephritis of the rat has been reported to be 52 d (30) . A direct comparison of these results is of doubtful value since the mode of binding with the glomerular capillary walls is different.
Recent studies have provided evidence that in situ immune complex formation, which may be a cause of tissue injury in various organs (31, 32) , can result in glomerular injury (1) (2) (3) (4) (5) (6) . In passive Heymans nephritis, it has been shown (1) that the GBM contains antigen similar to F×IA, found in the brush border of proximal tubular epithelial cells, either as intrinsic or planted antigen, which serves as a target for circulating antibody in the rat. Using heterologous antiserum, the total quantity of kidney-fixing antibody was shown to exceed 100 #g/kidney (33). Proteinuria did not usually reach a level of >100 mg/d from both kidneys (2, 33) . In our study, proteinuria from a single kidney exceeded 100 mg/d after the deposition of -30 #g of heterologous antibody before autologous rat IgG was detectable by immunofluorescence. Thus, there appear to be quantitative differences between our model and passive Heymans nephritis, although subepithelial dense deposits are prominent in both cases (2, 34) . The glomerulus has other features that may promote in situ glomerular immune complex formation. Golbus and Wilson used the glycoproteinbinding property of the lectin concanavalin A (Con A) to plant it in the glomerular capillary wall. Systemic injection of anti-Con A antibodies resulted in in situ immune complex formation and proliferative glomerulonephritis (3) . In this latter model the proteinuria induced lay within the range of 16-51 mg/d. The site of immune complex formation seems to be on the endothelial side of the GBM, because binding of Con A could be easily reduced by subsequent perfusion of alpha-methyl-mannoside. The existence of complexes exclusively subendothelially may result in a less severe injury to the glomerular capillary wall. The mechanism of in situ complex formation is now seriously considered to operate in acute serum sickness nephritis, as experiments with isolated kidneys showed that alternating perfusion with BSA and anti-BSA resulted in subepithelial complex formation, whereas preformed immune complex failed to localize (35) .
Recently, data were presented (36) concerning the relationship between glomerular permeability and the anionic glycosaminoglycan (GAG). In this work, the anionic component GAG in the lamina rara interna and externa was considered to be important in regulating the permeability of the glomerular capillary wall. The loss of these anionic sites following treatment with a specific enzyme, heparinase, remarkably enhanced both the penetration of native ferritin into the GBM and its excretion into the urinary space, whereas other enzymes such as hyaluronidase and chondroitinase ABC had no effect. The interaction of cationic antigen-antibody complex with the GBM could lead to a decrease or an alteration of the fixed anionic sites, resulting in a disturbance of glomerular permeability.
Summary
Cationized human IgG can bind to the rat glomerular basement membrane (GBM), act as planted antigen, and induce in situ immune complex formation accompanied by severe glomerulonephritis. Perfusion of highly cationized human IgG (isoelectric point > 9.5) via the left renal artery resulted in preferential localization within the perfused kidney (up to 56% of dose injected); after intravenous administration, only 4% was bound to the kidneys. The planted antigen was localized along the glomerular capillary walls and was accessible for antibody administered intravenously 1 h after perfusion, when virtually no antigen remained in the circulation.
Persistence of cationized human IgG in the perfused kidney was markedly prolonged when complexed with antibody; one-half the cationized human IgG was still present after 12 d. There was a difference in the disappearance rates of antigen and antibody, as cationized human IgG was removed faster from the kidney than the antibody, the binding of which remained almost unchanged during the first week. Renal perfusion of a minimum of 20 #g of cationized human IgG, followed by intravenous injection of antibody, regularly induced severe glomerulonephritis with a proteinuria of at least 100 mg/24 h. The degree and the persistence of proteinuria induced depended on the dose of cationized human IgG perfused.
Experiments using radiolabeled antigen and antibody showed that after renal perfusion of 20/~g cationized human IgG, 11.1 #g was kidney bound at the time of antibody injection. At the onset of proteinuria, 4.0 #g of antigen and 31.9 #g of antihuman IgG antibody were present in the perfused kidney. Immunofluorescence revealed immune deposits consisting of cationized human IgG and rabbit IgG (antihuman IgG) along the GBM. The staining pattern was linear (confluent) during the first 2 d and became granular during the course of the disease. Electronmicroscopically, a prominent finding was the accumulation of dense deposits, mainly in the subepithelial space and beneath the slit pores.
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